Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study
Françoise Kraeber‐Bodéré, Sonja Zweegman, Aurore Perrot, Cyrille Hulin, Denis Caillot, Thierry Façon, Xavier Leleu, Karim Belhadj, Emmanuel Itti, Lionel Karlin, Clément Bailly, Mark‐David Levin, Monique C. Minnema, Bastien Jamet, Caroline Bodet‐Milin, Bart De Keizer, Marie C. Béné, Hervé Avet‐Loiseau, Pieter Sonneveld, Lixia Pei, Fabio Rigat, Carla de Boer, Jessica Vermeulen, Tobias Kampfenkel, Jérôme Lambert, Philippe Moreau
Abstract
Funding Information: This study was funded by the Intergroupe Francophone du Myélome (IFM) and the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and was supported in part by grants from the French National Agency for Research called “Investissements d’Avenir” IRON Labex n◦ ANR-11-LABX-0018-01 and by a grant from INCa-DGOS-Inserm_12558 (SIRIC ILIAD).